Saba Capital Management, L.P. sold HQL

March 28, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 3,602 shares of Abrdn Life Sciences Investors at $12.95 per share, a transaction worth $46.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.